ERICA OROZCO: Open Payments
NPI 1922511724 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$782 in 32 payments from 11 companies in 2025. Trend: 2023 $218 · 2024 $323 · 2025 $782
Food & beverage: $782
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 17 | $348 |
| Medtronic, Inc. | 1 | $154 |
| Merck Sharp & Dohme LLC | 3 | $64 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $49 |
| Kestra Medical Technology Services, Inc. | 1 | $38 |
| Amgen Inc. | 2 | $34 |
| SCPHARMACEUTICALS INC. | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| PFIZER INC. | 1 | $18 |
| Organogenesis Inc. | 1 | $17 |
Products named: LEQVIO, VENASEAL, VERQUVO, Kerendia, Assure WCD, REPATHA, FUROSCIX, JARDIANCE.
Industry payments across TX — which companies pay providers there.
